phenylmethylsulfonyl fluoride has been researched along with Leg Ulcer in 1 studies
Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.
Leg Ulcer: Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Latijnhouwers, MA | 1 |
| Bergers, M | 1 |
| Veenhuis, RT | 1 |
| Beekman, B | 1 |
| Ankersmit-Ter Horst, MF | 1 |
| Schalkwijk, J | 1 |
1 other study available for phenylmethylsulfonyl fluoride and Leg Ulcer
| Article | Year |
|---|---|
Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity.
Topics: Extracellular Matrix; Exudates and Transudates; Humans; Leg Ulcer; Metalloendopeptidases; Pancreatic | 1998 |